Literature DB >> 10426928

Scleromyxedema.

Z Bata-Csorgo1, S Husz, M Foldes, I Korom, K Molnar, M Morvay, A Dobozy.   

Abstract

Scleromyxedema is a sclerotic variant of papular mucinosis, in which lichenoid papules and scleroderma-like features are present. We describe a patient with scleromyxedema with IgG type lambda chain paraprotein, a systemic sclerosis-like illness, and myositis. The patient's serum contained Scl 70 antibodies, characteristic of scleroderma. Electromyography showed signs of acute myositis and the creatine phosphokinase (CPK) level was elevated. Multiply passaged fibroblasts from the patient's skin lesions showed altered growth response in vitro. The patient was treated with cyclosporin (4 mg/kg/day) with improvement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426928     DOI: 10.1016/s0190-9622(99)70383-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

2.  [Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin].

Authors:  S Topf; M Simon; H Schell; M Lüftl
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

3.  [Differential diagnose of angioedema. Acute edematous scleromyxedema].

Authors:  S Gerstner; H Kneitz; E-B Bröcker; A Trautmann
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

4.  Scleromyxedema: a case report and review of the literature.

Authors:  Mohamed Allam; Mohamed Ghozzi
Journal:  Case Rep Dermatol       Date:  2013-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.